Xin-Fan Liu
Overview
Explore the profile of Xin-Fan Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
707
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li N, Zhu Y, Liu L, Feng Y, Wang W, Wang J, et al.
JAMA Netw Open
. 2021 Nov;
4(11):e2136116.
PMID: 34846525
Importance: Several studies have explored the efficacy and toxic effects of concurrent 5-fluorouracil (5-FU)- or capecitabine-based chemoradiotherapy (CRT) with or without oxaliplatin in the neoadjuvant setting. Addition of oxaliplatin to...
2.
Wang S, Fang H, Hu C, Song Y, Wang W, Jin J, et al.
J Clin Oncol
. 2020 Aug;
38(31):3604-3614.
PMID: 32780661
Purpose: No randomized trials have compared hypofractionated radiotherapy (HFRT) with conventional fractionated radiotherapy (CFRT) after breast-conserving surgery in the Asian population. This study aimed to determine whether a 3.5-week schedule...
3.
Sun G, Wang S, Song Y, Jin J, Wang W, Liu Y, et al.
Int J Radiat Oncol Biol Phys
. 2020 Mar;
108(1):277-285.
PMID: 32147519
Purpose: The aim of this study was to determine whether radiation-induced lymphopenia affects the survival of patients with breast cancer. Methods And Materials: Post hoc analysis was conducted on data...
4.
Wang S, Fang H, Song Y, Wang W, Hu C, Liu Y, et al.
Lancet Oncol
. 2019 Feb;
20(3):352-360.
PMID: 30711522
Background: To our knowledge, no randomised study has compared postmastectomy hypofractionated radiotherapy with conventional fractionated radiotherapy in patients with breast cancer. This study aimed to determine whether a 3-week schedule...
5.
Feng Y, Jin J, Ren H, Wang X, Wang S, Wang W, et al.
BMC Cancer
. 2017 Mar;
17(1):182.
PMID: 28279170
Background: In this era of oxaliplatin-based adjuvant therapy, the optimal sequence in which chemoradiotherapy should be administered for pathological stage N2 rectal cancer is unknown. The aim of this study...
6.
Zhang T, Zhao Y, Wang Z, Li C, Jin J, Jia A, et al.
Medicine (Baltimore)
. 2016 May;
95(21):e3789.
PMID: 27227954
Three-dimensional conformal radiotherapy in combination with transarterial chemoembolization (TACE) has been beneficial in patients with unresectable hepatocellular carcinoma (HCC). There have been few clinical reports on the use of intensity-modulated...
7.
Feng Y, Zhu Y, Liu L, Wang W, Wang S, Song Y, et al.
Oncotarget
. 2016 Mar;
7(18):25576-84.
PMID: 27014909
The aim of this study is to present an interim analysis of a phase III trial (NCT00714077) of postoperative concurrent capecitabine and radiotherapy with or without oxaliplatin for pathological stage...
8.
Jing H, Wang S, Li J, Xue M, Xiong Z, Jin J, et al.
Int J Radiat Oncol Biol Phys
. 2015 Sep;
93(2):268-76.
PMID: 26383676
Purpose: To map the location of metastatic supraclavicular (SCV) lymph nodes (LNMs) in breast cancer patients with SCV node involvement and determine whether and where the radiation therapy clinical target...
9.
Wang W, Wang Z, Wu J, Zhang T, Rong W, Wang L, et al.
Liver Int
. 2015 May;
35(12):2603-10.
PMID: 25939444
Background & Aims: To investigate the role of post-operative intensity-modulated radiotherapy (IMRT) in patients receiving narrow-margin hepatectomy for hepatocellular carcinoma (HCC) located close to the major vessels. Methods: This exploratory...
10.
Lu N, Jin J, Wang S, Wang W, Song Y, Liu Y, et al.
PLoS One
. 2015 Apr;
10(4):e0124601.
PMID: 25915948
Background: The aim of this study was to evaluate the survival outcomes and toxicity of postoperative chemoradiotherapy with capecitabine and concurrent intensity-modulated radiotherapy (IMRT) or three-dimensional conformal radiotherapy (3D-CRT) in...